|
1
|
Chow WH, Dong LM and Devesa SS:
Epidemiology and risk factors for kidney cancer. Nat Rev Urol.
7:245–257. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Patard JJ, Pignot G, Escudier B, Eisen T,
Bex A, Sternberg C, Rini B, Roigas J, Choueiri T, Bukowski R, et
al: ICUD-EAU international consultation on kidney cancer 2010:
Treatment of metastatic disease. Eur Urol. 60:684–690. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arabsalmani M, Mohammadian-Hafshejani A,
Ghoncheh M, Hadadian F, Towhidi F, Vafaee K and Salehiniya H:
Incidence and mortality of kidney cancers, and human development
index in Asia; a matter of concern. J Nephropathol. 6:30–42. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Waalkes S, Kramer M, Herrmann TR, Schrader
AJ, Kuczyk MA and Merseburger AS: Present state of target therapy
for disseminated renal cell carcinoma. Immunotherapy. 2:393–398.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duran I, Lambea J, Maroto P,
González-Larriba JL, Flores L, Granados-Principal S, Graupera M,
Sáez B, Vivancos A and Casanovas O: Resistance to targeted
therapies in renal cancer: The importance of changing the mechanism
of action. Target Oncol. 12:19–35. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu H, Li J, Koirala P, Ding X, Chen B,
Wang Y, Wang Z, Wang C, Zhang X and Mo YY: Long non-coding RNAs as
prognostic markers in human breast cancer. Oncotarget.
7:20584–20596. 2016.PubMed/NCBI
|
|
9
|
Xu Z, Zhou Y, Cao Y, Dinh TL, Wan J and
Zhao M: Identification of candidate biomarkers and analysis of
prognostic values in ovarian cancer by integrated bioinformatics
analysis. Med Oncol. 33:1302016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
von Roemeling CA, Radisky DC, Marlow LA,
Cooper SJ, Grebe SK, Anastasiadis PZ, Tun HW and Copland JA:
Neuronal pentraxin 2 supports clear cell renal cell carcinoma by
activating the AMPA-selective glutamate receptor-4. Cancer Res.
74:4796–4810. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wozniak MB, Le Calvez-Kelm F,
Abedi-Ardekani B, Byrnes G, Durand G, Carreira C, Michelon J,
Janout V, Holcatova I, Foretova L, et al: Integrative genome-wide
gene expression profiling of clear cell renal cell carcinoma in
Czech Republic and in the United States. PLoS One. 8:e578862013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen B, Liu J, Ho TT, Ding X and Mo YY:
ERK-mediated NF-kB activation through ASIC1 in response to
acidosis. Oncogenesis. 5:e2792016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
da Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
da Huang W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barata PC and Rini BI: Treatment of renal
cell carcinoma: Current status and future directions. CA Cancer J
Clin. 67:507–524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schonenberger D, Rajski M, Harlander S and
Frew IJ: Vhl deletion in renal epithelia causes HIF-1α-dependent,
HIF-2α-independent angiogenesis and constitutive diuresis.
Oncotarget. 7:60971–60985. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tostain J, Li G, Gentil-Perret A and
Gigante M: Carbonic anhydrase 9 in clear cell renal cell carcinoma:
A marker for diagnosis, prognosis and treatment. Eur J Cancer.
46:3141–3148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaya K, Ayan S, Gokce G, Kilicarslan H,
Yildiz E and Gultekin EY: Urinary nuclear matrix protein 22 for
diagnosis of renal cell carcinoma. Scand J Urol Nephrol. 39:25–29.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jones J, Otu H, Spentzos D, Kolia S, Inan
M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, et al: Gene
signatures of progression and metastasis in renal cell cancer. Clin
Cancer Res. 11:5730–5739. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Herrem CJ, Tatsumi T, Olson KS, Shirai K,
Finke JH, Bukowski RM, Zhou M, Richmond AL, Derweesh I, Kinch MS
and Storkus WJ: Expression of EphA2 is prognostic of disease-free
interval and overall survival in surgically treated patients with
renal cell carcinoma. Clin Cancer Res. 11:226–231. 2005.PubMed/NCBI
|
|
22
|
Dessau M, Halimi Y, Erez T, Chomsky-Hecht
O, Chamovitz DA and Hirsch JA: The Arabidopsis COP9 signalosome
subunit 7 is a model PCI domain protein with subdomains involved in
COP9 signalosome assembly. Plant Cell. 20:2815–2834. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Beli P, Lukashchuk N, Wagner SA, Weinert
BT, Olsen JV, Baskcomb L, Mann M, Jackson SP and Choudhary C:
Proteomic investigations reveal a role for RNA processing factor
THRAP3 in the DNA damage response. Mol Cell. 46:212–225. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gummlich L, Rabien A, Jung K and Dubiel W:
Deregulation of the COP9 signalosome-cullin-RING ubiquitin-ligase
pathway: Mechanisms and roles in urological cancers. Int J Biochem
Cell Biol. 45:1327–1337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Feist M, Huang X, Müller JM, Rau B and
Dubiel W: Can hyperthermic intraperitoneal chemotherapy efficiency
be improved by blocking the DNA repair factor COP9 signalosome? Int
J Colorectal Dis. 29:673–680. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rozen S, Tieri A, Ridner G, Stark AK,
Schmaler T, Ben-Nissan G, Dubiel W and Sharon M: Exposing the
subunit diversity within protein complexes: A mass spectrometry
approach. Methods. 59:270–277. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen B, Duan L, Yin G, Tan J and Jiang X:
Simultaneously expressed miR-424 and miR-381 synergistically
suppress the proliferation and survival of renal cancer cells-Cdc2
activity is up-regulated by targeting WEE1. Clinics (Sao Paulo).
68:825–833. 2013. View Article : Google Scholar : PubMed/NCBI
|
